DOI:
10.1055/s-00035026
Applied Clinical Informatics
LinksClose Window
References
Sokka T, Pincus T.
Eligibility of patients in routine care for major clinical trials of anti–tumor necrosis factor á agents in rheumatoid arthritis.
Arthritis & Rheumatism 2003;
48 (Suppl. 02) 313-318.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.